Abstract
Components of metabolic syndrome, including elevated serum insulin and C-peptide levels, seem to affect risk of developing prostate cancer, but inconsistently. Recently, an inverse association was reported in a prospective U.S. study ([1][1]), whereas a prospective Norwegian study reported the
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have